Prostate Cancer

Prostate Cancer
2024-11-20T06:32:33.603Z

AAA617-Lu-Prostate

AAA617-Lu-Prostate
Prostate cancer

An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617) versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen (PSMA) positive Oligometastatic Prostate Cancer (OMPC)

An International, Prospective, Open-label, Multi-center, Randomized Phase III Study comparing lutetium (177Lu) vipivotide tetraxetan (AAA617) versus Observation to delay castration or disease recurrence in adult male patients with prostate-specific membrane antigen (PSMA) positive Oligometastatic Prostate Cancer (OMPC)

Trial overview

Clinical Area

Theranostics

Disease / Condition

Prostate

Study Phase

III

GenesisCare Location(s)
Cabrini (Gandel Wing)
location pin icon

Cabrini Hospital Malvern, Level B4, Gandel Wing, 183 Wattletree Road, Malvern, VIC, 3144, Australia

phone icon (03) 9597 6900 email icon cabrinireception@genesiscare.com
VIC
Cabrini (Gandel Wing)
Principal Investigator(s)
Radiation Oncologist

A/Prof. Michael Ng

MBBS (Hons), FRANZCR

A/Prof. Michael Ng
location pin icon

St Vincent's Melbourne (Oncology) +2

View Profile
Profile Image - A/Prof. Michael Ng

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.